Indoco Remedies Limited (INDOCO) - Total Assets

Latest as of March 2026: Rs25.93 Billion INR ≈ $280.45 Million USD

Based on the latest financial reports, Indoco Remedies Limited (INDOCO) holds total assets worth Rs25.93 Billion INR (≈ $280.45 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore Indoco Remedies Limited (INDOCO) cash flow to debt to assess how comfortably operating cash covers total debt obligations.

Indoco Remedies Limited - Total Assets Trend (2004–2026)

This chart illustrates how Indoco Remedies Limited's total assets have evolved over time, based on quarterly financial data. See INDOCO net asset value for net asset value and shareholders' equity analysis.

Indoco Remedies Limited - Asset Composition Analysis

Current Asset Composition (March 2026)

Indoco Remedies Limited's total assets of Rs25.93 Billion consist of 46.0% current assets and 54.0% non-current assets.

Asset Category Amount (INR) % of Total Assets
Cash & Equivalents Rs0.00 1.3%
Accounts Receivable Rs4.94 Billion 19.0%
Inventory Rs4.05 Billion 15.6%
Property, Plant & Equipment Rs0.00 0.0%
Intangible Assets Rs1.79 Billion 6.9%
Goodwill Rs215.20 Million 0.8%

Asset Composition Trend (2004–2026)

This chart illustrates how Indoco Remedies Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see INDOCO market cap overview.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Indoco Remedies Limited's current assets represent 46.0% of total assets in 2026, a decrease from 67.1% in 2004.
  • Cash Position: Cash and equivalents constituted 1.3% of total assets in 2026, down from 4.2% in 2004.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 6.0% of total assets, an increase from 0.0% in 2004.
  • Asset Diversification: The largest asset category is accounts receivable at 19.0% of total assets.

Indoco Remedies Limited Competitors by Total Assets

Key competitors of Indoco Remedies Limited based on total assets are shown below.

Company Country Total Assets
Tianjin Zhongxin Pharmaceutical Group Corp Ltd
SHG:600329
China CN¥11.59 Billion
Chengdu Kanghong Pharmaceuticals Group Co Ltd
SHE:002773
China CN¥10.21 Billion
China Resources Double-Crane Pharmaceutical Co Ltd
SHG:600062
China CN¥17.01 Billion
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267
China CN¥13.81 Billion
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
Germany €1.60 Trillion
Zhejiang Tianyu Pharmaceutical Co Ltd
SHE:300702
China CN¥6.56 Billion
Zhejiang Garden Bio-chemical High-tech Co Ltd
SHE:300401
China CN¥5.91 Billion
KPC Pharmaceuticals Inc
SHG:600422
China CN¥12.01 Billion

Indoco Remedies Limited - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.13 1.24 1.53
Quick Ratio 0.75 0.72 0.95
Cash Ratio 0.00 0.02 0.00
Working Capital Rs1.41 Billion Rs1.93 Billion Rs2.16 Billion

Indoco Remedies Limited - Advanced Valuation Insights

This section examines the relationship between Indoco Remedies Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 2.36
Latest Market Cap to Assets Ratio 0.01
Asset Growth Rate (YoY) 6.7%
Total Assets Rs25.93 Billion
Market Capitalization $245.06 Million USD

Valuation Analysis

Below Book Valuation: The market values Indoco Remedies Limited's assets below their book value (0.01x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Indoco Remedies Limited's assets grew by 6.7% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Indoco Remedies Limited (2004–2026)

The table below shows the annual total assets of Indoco Remedies Limited from 2004 to 2026.

Year Total Assets Change
2026-03-31 Rs25.93 Billion
≈ $280.45 Million
+6.72%
2025-03-31 Rs24.30 Billion
≈ $262.79 Million
+13.30%
2024-03-31 Rs21.45 Billion
≈ $231.94 Million
+29.34%
2023-03-31 Rs16.58 Billion
≈ $179.33 Million
+11.58%
2022-03-31 Rs14.86 Billion
≈ $160.72 Million
+13.01%
2021-03-31 Rs13.15 Billion
≈ $142.22 Million
+3.42%
2020-03-31 Rs12.72 Billion
≈ $137.52 Million
+1.08%
2019-03-31 Rs12.58 Billion
≈ $136.05 Million
+1.76%
2018-03-31 Rs12.36 Billion
≈ $133.70 Million
+3.28%
2017-03-31 Rs11.97 Billion
≈ $129.45 Million
+24.20%
2016-03-31 Rs9.64 Billion
≈ $104.23 Million
+13.97%
2015-03-31 Rs8.46 Billion
≈ $91.45 Million
+15.93%
2014-03-31 Rs7.29 Billion
≈ $78.88 Million
+5.81%
2013-03-31 Rs6.89 Billion
≈ $74.55 Million
+5.02%
2012-03-31 Rs6.56 Billion
≈ $70.98 Million
+16.26%
2011-03-31 Rs5.65 Billion
≈ $61.06 Million
+17.85%
2010-03-31 Rs4.79 Billion
≈ $51.81 Million
+15.24%
2009-03-31 Rs4.16 Billion
≈ $44.96 Million
+11.00%
2008-03-31 Rs3.75 Billion
≈ $40.50 Million
+7.93%
2007-03-31 Rs3.47 Billion
≈ $37.53 Million
+11.69%
2006-03-31 Rs3.11 Billion
≈ $33.60 Million
+9.05%
2005-03-31 Rs2.85 Billion
≈ $30.81 Million
+89.27%
2004-03-31 Rs1.51 Billion
≈ $16.28 Million
--

About Indoco Remedies Limited

NSE:INDOCO India Drug Manufacturers - Specialty & Generic
Market Cap
$245.06 Million
Rs22.66 Billion INR
Market Cap Rank
#15661 Global
#810 in India
Share Price
Rs245.84
Change (1 day)
+0.53%
52-Week Range
Rs164.00 - Rs324.50
All Time High
Rs511.66
About

Indoco Remedies Limited manufactures and markets formulations and active pharmaceutical ingredients in India and internationally. It offers products for gastrointestinal, anti-infectives, respiratory, stomatological, vitamins/minerals/nutrients, urological, ophthal/ontological, dermatology, pain/analgesic, cardiac, anti-diabetic, and gynaecological therapeutic areas. The company also provides bra… Read more